Healio

FDA clears updated Alaris infusion pump; recall remediation remains ‘top priority’

Please provide your email address to receive an email when new articles are posted on . The FDA granted 510(k) clearance to Becton Dickinson’s updated Alaris infusion pump, allowing the company to ...

Becton Dickinson AI Partnership With Wellstar Tests Connected Devices Thesis

Becton Dickinson (NYSE:BDX) is partnering with Wellstar Health System to roll out AI powered medication dispensing and ...
FierceBiotech

CareFusion recalls its Alaris infusion pump, the franchise's 9th Class 1 recall since 2010

CareFusion is recalling 7,418 units of its Alaris Syringe infusion pump, a corrective action that the FDA just deemed Class 1. This marks CareFusion's ninth Class 1 recall of an Alaris device since ...
Seeking Alpha

BD Receives FDA 510(k) Clearance for Updated BD Alaris™ Infusion System

To address all open recalls and ensure all devices at customer sites are running the most recent version of the BD Alaris™ Infusion System Software, all of the current Alaris devices in the U.S.
FierceBiotech

FDA doles out Class I rating to recall of replacement part for BD's Alaris infusion pump

A new group of recalls for a repair piece installed in some of BD’s Alaris infusion pumps joins more than a dozen others on the long list of serious recalls involving the device in the last decade.
WDAF-TV

BD Receives FDA 510(k) Clearance for Updated BD Alaris™ Infusion System

FRANKLIN LAKES, N.J., July 21, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that the updated BD Alaris™ Infusion ...